For the quarter ending 2025-10-26, SMTC had -$3,890K decrease in cash & cash equivalents over the period. $44,643K in free cash flow.
| Cash Flow | 2025-10-26 | 2025-07-27 | 2025-04-27 | 2025-01-26 |
|---|---|---|---|---|
| Net loss | -2,862 | -27,064 | 220,385 | - |
| Depreciation and amortization | 10,129 | 10,314 | -23,021 | - |
| Amortization of right-of-use assets | 1,392 | 1,356 | -3,196 | - |
| Investment impairments and credit loss reserves, net | 0 | 0 | -1,109 | - |
| Goodwill impairment | 0 | 41,991 | - | - |
| Accretion of deferred financing costs | 1,172 | 1,271 | -5,560 | - |
| Write-off of deferred financing costs | 1,872 | 364 | -5,345 | - |
| Loss on extinguishment of debt | 0 | 143,467 | - | - |
| Induced conversion expense | 21,188 | - | - | - |
| Interest rate swap termination | 416 | 743 | -14 | - |
| Deferred income taxes | -2,935 | -2,437 | -3,355 | - |
| Share-based compensation | 17,138 | 17,297 | -43,942 | - |
| Loss on disposition of business operations and assets | 1 | -16 | 98 | - |
| Equity method income | 16 | -62 | 1,008 | - |
| Gain from sale of investments | 0 | 0 | -277 | - |
| Corporate-owned life insurance, net | -820 | -734 | 2,067 | - |
| Accounts receivable, net | 11,317 | -12,325 | -5,035 | - |
| Inventories | 2,449 | 13,001 | -11,819 | - |
| Other assets | 2,778 | 5,051 | -1,684 | - |
| Accounts payable | 4,416 | 1,420 | -9,106 | - |
| Accrued liabilities | 6,040 | 4,004 | -6,631 | - |
| Other liabilities | 199 | -3,337 | 5,314 | - |
| Net cash provided by operating activities | 47,462 | 44,395 | 27,824 | 33,496 |
| Proceeds from sale of business, net of cash disposed | - | - | - | 0 |
| Proceeds from sales of property, plant and equipment | 0 | 3 | - | 24 |
| Purchase of property, plant and equipment | 2,819 | 2,884 | 1,650 | 2,633 |
| Proceeds from sale of investments | 1,400 | 0 | 536 | 0 |
| Purchase of investments | 0 | 0 | - | 0 |
| Purchase of intangibles | 2,635 | 2,250 | 529 | 393 |
| Proceeds from revolving line of credit | - | - | - | 68,250 |
| Proceeds from corporate-owned life insurance | 0 | 0 | 0 | 0 |
| Proceeds from sale of warrants | - | - | - | 0 |
| Acquisition, net of cash acquired | - | - | - | 0 |
| Premiums paid for corporate-owned life insurance | 0 | 0 | 3,428 | 4,800 |
| Proceeds from term loans | - | - | - | 0 |
| Net cash used in investing activities | -4,054 | -5,131 | -5,071 | -7,802 |
| Proceeds from issuance of common stock, net of issuance costs | - | - | - | 640,675 |
| Payments of revolving line of credit | 0 | - | - | 278,250 |
| Proceeds from interest rate swap termination | - | - | - | 4,776 |
| Payments of term loans | 181,212 | - | - | 441,413 |
| Proceeds from convertible senior notes | 402,500 | - | - | 0 |
| Payments of convertible senior notes | 280,950 | - | - | - |
| Repurchase of warrants | 217,761 | - | - | - |
| Proceeds from unwind of convertible note hedge | 242,251 | - | - | - |
| Purchase of capped calls | 31,395 | - | - | - |
| Proceeds from interest rate swap termination | 58 | 237 | - | - |
| Deferred financing costs | 10,062 | 72 | 492 | 0 |
| Payments of term loans | - | 25,000 | 10,000 | - |
| Payments for employee share-based compensation payroll taxes | 6,553 | 3,290 | 8,901 | 6,728 |
| Repurchase of common stock | - | - | - | 0 |
| Proceeds from exercise of stock options | 1,038 | 468 | 32 | 3,087 |
| Purchase of convertible note hedge | - | - | - | 0 |
| Distributions to noncontrolling interest | 0 | 0 | 0 | 0 |
| Net cash used in financing activities | -47,086 | -27,657 | -19,361 | -9,603 |
| Effect of foreign exchange rate changes on cash and cash equivalents | -212 | 479 | 1,339 | -852 |
| Net increase in cash and cash equivalents | -3,890 | 12,086 | 4,731 | 15,239 |
| Cash and cash equivalents at beginning of period | 151,743 | - | - | - |
| Cash and cash equivalents at end of period | 164,670 | - | - | - |
SEMTECH CORP (SMTC)
SEMTECH CORP (SMTC)